Daniel Poon - Caribou Biosciences Vice Technology
| CRBU Stock | USD 3.39 0.20 5.57% |
Executive
Daniel Poon is Vice Technology of Caribou Biosciences
| Address | 2929 7th Street, Berkeley, CA, United States, 94710 |
| Phone | 510 982 6030 |
| Web | https://cariboubio.com |
Caribou Biosciences Management Efficiency
The company has return on total asset (ROA) of (0.217) % which means that it has lost $0.217 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3709) %, meaning that it created substantial loss on money invested by shareholders. Caribou Biosciences' management efficiency ratios could be used to measure how well Caribou Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.24 in 2024. Return On Capital Employed is likely to drop to -0.3 in 2024. Total Current Liabilities is likely to drop to about 23 M in 2024. Liabilities And Stockholders Equity is likely to drop to about 298.1 M in 2024Similar Executives
| Found 6 records | EXECUTIVE Age | ||
| Quinton McGeer | Barloworld Ltd ADR | 58 | |
| Nigel MSc | Virax Biolabs Group | N/A | |
| James Wang | Virax Biolabs Group | N/A | |
| Joel Yeung | Virax Biolabs Group | N/A | |
| Lily Fu | Virax Biolabs Group | N/A | |
| Clement Monteil | Virax Biolabs Group | N/A | |
Management Performance
| Return On Equity | -0.37 | ||||
| Return On Asset | -0.22 |
Caribou Biosciences Leadership Team
Elected by the shareholders, the Caribou Biosciences' board of directors comprises two types of representatives: Caribou Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Caribou. The board's role is to monitor Caribou Biosciences' management team and ensure that shareholders' interests are well served. Caribou Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Caribou Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Amy CFA, Vice Communications | ||
| Cindy Hayashi, VP HR | ||
| Ryan Fischesser, Vice Controller | ||
| Jason MBA, Chief Officer | ||
| JD Esq, Chief Secretary | ||
| Timothy MBA, Chief Officer | ||
| Reigin Zawadzki, Chief Officer | ||
| Syed MD, Chief Officer | ||
| Rachel Haurwitz, CEO, CoFounder | ||
| Steven Kanner, Chief Officer | ||
| Ruhi MBA, Chief Officer | ||
| Justin Skoble, VP Operations | ||
| Daniel Poon, Vice Technology |
Caribou Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Caribou Biosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.37 | ||||
| Return On Asset | -0.22 | ||||
| Operating Margin | (18.94) % | ||||
| Current Valuation | 39.35 M | ||||
| Shares Outstanding | 90.32 M | ||||
| Shares Owned By Insiders | 10.05 % | ||||
| Shares Owned By Institutions | 76.87 % | ||||
| Number Of Shares Shorted | 10.64 M | ||||
| Price To Book | 1.03 X | ||||
| Price To Sales | 11.00 X |
Pair Trading with Caribou Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Caribou Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Caribou Stock
| 0.78 | VXRT | Vaxart Inc | PairCorr |
Moving against Caribou Stock
| 0.84 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
| 0.84 | MAIA | MAIA Biotechnology | PairCorr |
| 0.78 | LPCN | Lipocine | PairCorr |
| 0.7 | MNMD | Mind MedicineInc | PairCorr |
| 0.69 | SLS | Sellas Life Sciences | PairCorr |
The ability to find closely correlated positions to Caribou Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Caribou Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Caribou Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Caribou Biosciences to buy it.
The correlation of Caribou Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Caribou Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Caribou Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Caribou Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caribou Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy Caribou Stock please use our How to Invest in Caribou Biosciences guide.Note that the Caribou Biosciences information on this page should be used as a complementary analysis to other Caribou Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Caribou Stock analysis
When running Caribou Biosciences' price analysis, check to measure Caribou Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caribou Biosciences is operating at the current time. Most of Caribou Biosciences' value examination focuses on studying past and present price action to predict the probability of Caribou Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caribou Biosciences' price. Additionally, you may evaluate how the addition of Caribou Biosciences to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Caribou Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Caribou Biosciences. If investors know Caribou will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Caribou Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.38) | Revenue Per Share 0.413 | Quarterly Revenue Growth (0.31) | Return On Assets (0.22) | Return On Equity (0.37) |
The market value of Caribou Biosciences is measured differently than its book value, which is the value of Caribou that is recorded on the company's balance sheet. Investors also form their own opinion of Caribou Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Caribou Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Caribou Biosciences' market value can be influenced by many factors that don't directly affect Caribou Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Caribou Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Caribou Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Caribou Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.